STOCK TITAN
  1. Home
  2. Sec-filings
  3. AVPT
  4. [Form 4/A] AvePoint, Inc. Amended Insider Trading Activity

AVPT Form 4/A: CEO adds option tranches at $1.34–$3.91

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

AvePoint (AVPT) filed an amended Form 4 reporting that its Chief Executive Officer and Director exercised multiple stock option tranches on 10/13/2025 under the 2016 Equity Incentive Plan. The amendment adds these specific tranches to the prior filing.

The transactions (code M) cover options for 569,707 shares at an exercise price of $1.34, 362,850 shares at $1.59, and 1,716,047 shares at $3.91, each into common stock. Following these entries, the reported remaining derivative securities beneficially owned declined sequentially to 3,000,104, with ownership shown as Direct. Table I reflects no separate non-derivative share transactions in this excerpt.

Positive

  • None.

Negative

  • None.

Insights

Amended Form 4 discloses CEO option exercises; no sales listed.

The filing records three option exercises (transaction code M) on 10/13/2025 under the 2016 Equity Incentive Plan. Tranches cover 569,707 at $1.34, 362,850 at $1.59, and 1,716,047 at $3.91, converting into common stock. Such amendments typically ensure the prior report includes all applicable tranches.

Ownership is reported as direct, and the table shows remaining derivative holdings stepping down to 3,000,104 after the entries. The excerpt’s Table I lists no non-derivative transactions, so cash-flow treatment and any subsequent share dispositions are not shown here.

Insider Jiang Tianyi
Role Chief Executive Officer
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 569,707 $0.00 $0.00
Exercise Stock Option (Right to Buy) 362,850 $0.00 $0.00
Exercise Stock Option (Right to Buy) 1,716,047 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 12,795,256 shares (Direct)
Footnotes (1)
  1. F1. The original Form 4, filed on October 15, 2025, is being amended by this Form 4 amendment to include these tranches on the list of options exercised by the Reporting Person in accordance with the 2016 Equity Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did AvePoint (AVPT) disclose in this Form 4/A?
An amendment adding specific CEO option exercise tranches executed on 10/13/2025 under the 2016 Equity Incentive Plan.

How many options did the AVPT CEO exercise and at what prices?
Three tranches: 569,707 at $1.34, 362,850 at $1.59, and 1,716,047 at $3.91.

Were any AvePoint common shares sold in this filing?
The excerpt lists option exercises (code M) and shows no separate non-derivative share sales in Table I.

What was the earliest transaction date reported?
The earliest transaction date reported is 10/13/2025.

What is the insider’s relationship to AvePoint (AVPT)?
The reporting person is a Director and Chief Executive Officer of AvePoint.

What was the ownership form after the transactions?
Ownership is indicated as Direct, with derivative securities beneficially owned stepping down to 3,000,104 after the entries.

Why was the Form 4 amended?
To include these tranches on the list of options exercised by the reporting person in accordance with the 2016 Equity Incentive Plan.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Jiang Tianyi
(Last) (First) (Middle)
C/O AVEPOINT, INC.
525 WASHINGTON BOULEVARD, SUITE 1400
(Street)
JERSEY CITY NJ 07310
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
10/15/2025 		6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)(1) $1.34 10/13/2025 M 569,707 07/01/2020 07/01/2026 Common Stock 569,707 $0 5,079,001 D
Stock Option (Right to Buy)(1) $1.59 10/13/2025 M 362,850 01/10/2023 01/10/2029 Common Stock 362,850 $0 4,716,151 D
Stock Option (Right to Buy)(1) $3.91 10/13/2025 M 1,716,047 08/12/2024 08/12/2030 Common Stock 1,716,047 $0 3,000,104 D
Explanation of Responses:
1. The original Form 4, filed on October 15, 2025, is being amended by this Form 4 amendment to include these tranches on the list of options exercised by the Reporting Person in accordance with the 2016 Equity Incentive Plan.
/s/ Brian Michael Brown, Attorney-in-Fact 10/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR